As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
On Monday, Triumph Group Inc. (NYSE:TGI)'s Director, John G. Drosdick, made a $346,048 purchase of TGI, buying 5,000 shares at a cost of $69.21 a piece. Triumph Group Inc. is trading up about 0.5% on the day Tuesday. Before this latest buy, Drosdick made one other buy in the past year, purchasing $321,312 shares for a cost of $64.26 a piece.
And on Thursday, Director Brigitte Smith purchased $200,000 worth of Kalobios Pharmaceuticals Incorporated (NASDAQ:KBIO), purchasing 25,000 shares at a cost of $8.00 each. This buy marks the first one filed by Smith in the past twelve months. Kalobios Pharmaceuticals Incorporated is trading trading flat on the day Tuesday. Investors can buy KBIO even cheaper than Smith did, with the stock trading as low as $7.90 in trading on Tuesday -- that's 1.2% below Smith's purchase price.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.